Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Dietz, Julia; Susser, Simone; Vermehren, Johannes; Peiffer, Kai-Henrik; Grammatikos, Georgios; Berger, Annemarie; Ferenci, Peter; Buti, Maria; Müllhaupt, Beat; Hunyady, Bela; Hinrichsen, Holger; Mauss, Stefan; Petersen, Jörg; Buggisch, Peter; Felten, Gisela; Hüppe, Dietrich; Knecht, Gaby; Lutz, Thomas; Schott, Eckart; Berg, Christoph; Spengler, Ulrich; von Hahn, Thomas; Berg, Thomas; Zeuzem, Stefan; Sarrazin, Christoph; European HCV Resistance Study Group (2018). Patterns of Resistance-associated Substitutions in Patients With Chronic HCV Infection Following Treatment with Direct-acting Antivirals. Gastroenterology, 154(4):976-988.e4.

Strasser, Michael; Stadlmayr, Andreas; Haufe, Heike; Stickel, Felix; Ferenci, Peter; Patsch, Wolfgang; Feldman, Alexandra; Weghuber, Daniel; Datz, Christian; Aigner, Elmar (2016). Natural course of subjects with elevated liver tests and normal liver histology. Liver International, 36(1):119-125.

Andreone, Pietro; Colombo, Massimo G; Enejosa, Jeffrey V; Koksal, Iftihar; Ferenci, Peter; Maieron, Andreas; Müllhaupt, Beat; Horsmans, Yves; Weiland, Ola; Reesink, Henk W; Rodrigues, Lino; Hu, Yiran B; Podsadecki, Thomas; Bernstein, Barry (2014). ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection. Gastroenterology, 147(2):359-365.e1.

Wlcek, Katrin; Koller, Fabienne; Ferenci, Peter; Stieger, Bruno (2013). Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin. Drug Metabolism and Disposition, 41(8):1522-1528.

This list was generated on Fri May 25 06:40:29 2018 CEST.